Rifampin recalls
The FDA has published 20 recalls involving Rifampin since 2014. The latest was reported on 17 Apr 2024. Most were for potency & assay. Akorn has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls20since 2014
Last 12 months0reported
Class I00% of total
Ongoing4latest 17 Apr 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 18 90%Class III 2 10%
Why rifampin is recalled
Companies
By year
Ongoing rifampin recalls
4 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Rifampin Capsules USP, 150 mg recalled by Akorn | Akorn | Sterility | Nationwide |
| Drug | CLASS II | Rifampin Capsules USP, 300 mg recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Rifampin Capsules, USP, 300 mg, a) bottle recalled by Akorn | Akorn | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Rifampin Capsules, USP, 150 mg recalled by Akorn | Akorn | Nitrosamine Impurity | Nationwide |
All rifampin recalls, newest first
20 totalShould you stop taking Rifampin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.